Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5460 USD | -4.38% |
|
-2.81% | +46.64% |
Dec. 23 | CbdMD, Inc. Appoints T. Ronan Kennedy to Its Board of Directors | CI |
Dec. 18 | CbdMD, Inc., Q4 2024 Earnings Call, Dec 18, 2024 |
Company Valuation: cbdMD, Inc.
Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 104.2 | 120.2 | 13.63 | 2.958 | 1.804 | 3.163 |
Change | - | 15.32% | -88.66% | -78.3% | -39.01% | 75.32% |
Enterprise Value (EV) | 89.71 | 93.93 | 13.63 | 2.958 | 1.804 | 3.163 |
Change | - | 4.71% | -85.49% | -78.3% | -39.01% | 75.32% |
P/E ratio | 7.14x | -4.43x | -0.18x | -0.08x | -0.26x | -0.64x |
PBR | - | - | - | - | - | - |
PEG | - | 0x | -0x | 0x | 0x | 0x |
Capitalization / Revenue | 2.49x | 2.7x | - | 0.12x | 0.09x | 0.15x |
EV / Revenue | 0x | 0x | - | 0x | 0x | 0.15x |
EV / EBITDA | -5.32x | -5.05x | - | - | - | - |
EV / EBIT | -0x | -0x | - | -0x | -0x | -2x |
EV / FCF | -7.49x | -6.51x | - | - | - | - |
FCF Yield | -0% | -0% | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - |
Rate of return | - | - | - | - | - | - |
EPS 2 | 12.6 | -21.15 | -55.8 | -13.32 | -1.79 | -0.89 |
Distribution rate | - | - | - | - | - | - |
Net sales 1 | 41.88 | 44.48 | - | 24.16 | 19.48 | 21.58 |
EBITDA | -16.86 | -18.6 | - | - | - | - |
EBIT 1 | -17.58 | -19.62 | - | -5.527 | -1.592 | -1.582 |
Net income 1 | 12.24 | -25.95 | -70.08 | -26.94 | -7.704 | -3.583 |
Net Debt | -14.5 | -26.24 | - | - | - | - |
Reference price 2 | 90.0000 | 93.6000 | 10.1295 | 1.0350 | 0.4700 | 0.5710 |
Nbr of stocks (in thousands) | 1,158 | 1,284 | 1,346 | 2,858 | 3,838 | 5,539 |
Announcement Date | 12/22/20 | 12/17/21 | 12/15/22 | 12/22/23 | 12/18/24 | - |
P/E ratio, Detailed evolution
P/E ratio (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|
-0.64x | - | - | - | 3.16M | ||
70.92x | 17.93x | 50.09x | 0.6% | 786B | ||
22.42x | 4.34x | 12.66x | 3.07% | 374B | ||
21.39x | 7.54x | 14.74x | 2.33% | 361B | ||
72.97x | 7.13x | 16.67x | 3.23% | 341B | ||
15.45x | 3.77x | 9.32x | 3.41% | 256B | ||
27.47x | 4.68x | 14.77x | 2.12% | 227B | ||
12.23x | 3.74x | 8.98x | 3.59% | 217B | ||
16.59x | 4.19x | 10.1x | 3.58% | 211B | ||
32.31x | 6.27x | 11.01x | 3.06% | 159B | ||
Average | 29.11x | 6.62x | 16.48x | percentage-no-prefix | 293.19B | |
Weighted average by Cap. | 40.32x | 8.73x | 22.74x | percentage-no-prefix |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- YCBD Stock
- Valuation cbdMD, Inc.